• Mon, June 3, 2013
  • Tue, June 4, 2013
  • Wed, June 5, 2013
  • Fri, June 7, 2013
  • Thu, June 6, 2013
  • Mon, June 10, 2013
  • Tue, June 11, 2013
  • Wed, June 12, 2013

Andrew Peters Upgraded (BMRN) to Strong Buy and Held Target at $75 on, Jun 3rd, 2013

Andrew Peters of Deutsche Bank, Upgraded "BioMarin Pharmaceutical Inc." (BMRN) to Strong Buy and Held Target at $75 on, Jun 3rd, 2013.

Andrew has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew


  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $70 on, Wednesday, March 20th, 2013
  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $71 on, Tuesday, February 12th, 2013


Similar Stocks and Investing Publications